Research progress of digital twin technology in tuberculosis prevention and control

doi:10.19982/j.issn.1000-6621.20260002

Abstract

Abstract:

As a new digital technology connecting the physical world and the digital world, digital twin technology provides new ideas and methods for tuberculosis prevention and control by creating a virtual model with real-time mapping and dynamic interaction. This paper systematically reviews the research progress of digital twin technology in the prediction, diagnosis, treatment and management of tuberculosis, focusing on its application value in epidemic simulation and transmission prediction, personalized diagnosis and treatment plan optimization, patient adherence management, etc., and discusses the current technical challenges such as data integration, model construction, and privacy protection. Finally, the future development direction is prospected, and it is pointed out that multimodal data fusion, artificial intelligence algorithm optimization, and multi-omics technology integration will be important development trends of digital twin technology in the field of tuberculosis prevention and control. The in-depth application of digital twin technology will help improve the accuracy and efficiency of tuberculosis prevention and control, and provide technical support for achieving the strategic goal of “ending the tuberculosis epidemic”.

Key words: Digital twin, Tuberculosis, Universal precautions, Personal health services

CLC Number:

Shan Liyan, Li Longfen, Li Wenming, Luo Yun, Zhang Huajie, Wang Ge, Huang Yuanqing, Li Shan, Wu Huachao, Shi Chunjing, Shen Lingjun. Research progress of digital twin technology in tuberculosis prevention and control[J]. Chinese Journal of Antituberculosis, 2026, 48(5): 700-706. doi: 10.19982/j.issn.1000-6621.20260002

Figures/Tables 1

References 55

[1]	Pai M, Behr MA, Dowdy D, et al. Tuberculosis. Nat Rev Dis Primers, 2016, 2:16076. doi:10.1038/nrdp.2016.76. URL pmid: 27784885
[2]	屈燕, 李涛, 马文斌, 等. 世界卫生组织《2025年全球结核病报告》解读. 结核与肺部疾病杂志, 2025, 6 (6): 613-623. doi:10.19983/j.issn.2096-8493.20250178.
[3]	Armeni P, Polat I, De Rossi LM, et al. Digital Twins in Healthcare: Is It the Beginning of a New Era of Evidence-Based Medicine? A Critical Review. J Pers Med, 2022, 12(8): 1255. doi:10.3390/jpm12081255.
[4]	Barricelli BR, Casiraghi E, Fogli D. A Survey on Digital Twin: Definitions, Characteristics, Applications, and Design Implications. IEEE Access, 2019, 7: 167653-167671. doi:10.1109/ACCESS.2019.2953499.
[5]	Emmert-Streib F, Yli-Harja O. What Is a Digital Twin? Experimental Design for a Data-Centric Machine Learning Perspective in Health. Int J Mol Sci, 2022, 23(21):13149. doi:10.3390/ijms232113149.
[6]	Yao JF, Yang Y, Wang XC, et al. Systematic review of digital twin technology and applications. Vis Comput Ind Biomed Art, 2023, 6(1): 10. doi:10.1186/s42492-023-00137-4.
[7]	Katsoulakis E, Wang Q, Wu H, et al. Digital twins for health: a scoping review. NPJ Digit Med, 2024, 7(1):77. doi:10.1038/s41746-024-01073-0. URL pmid: 38519626
[8]	Kamel Boulos MN, Zhang P. Digital Twins: From Persona-lised Medicine to Precision Public Health. J Pers Med, 2021, 11(8):745. doi:10.3390/jpm11080745.
[9]	Coorey G, Figtree GA, Fletcher DF, et al. The health digital twin to tackle cardiovascular disease-a review of an emerging interdisciplinary field. NPJ Digit Med, 2022, 5(1):126. doi:10.1038/s41746-022-00640-7. URL pmid: 36028526
[10]	Shamanna P, Dharmalingam M, Sahay R, et al. Retrospective study of glycemic variability, BMI, and blood pressure in diabetes patients in the Digital Twin Precision Treatment Program. Sci Rep, 2021, 11(1):14892. doi:10.1038/s41598-021-94339-6. URL pmid: 34290310
[11]	Sun T, He X, Li Z. Digital twin in healthcare: Recent updates and challenges. Digit Health, 2023, 9: 20552076221149651. doi:10.1177/20552076221149651.
[12]	Thangaraj PM, Benson SH, Oikonomou EK, et al. Cardiovascular care with digital twin technology in the era of generative artificial intelligence. Eur Heart J, 2024, 45(45): 4808-4821. doi:10.1093/eurheartj/ehae619. URL pmid: 39322420
[13]	Avanzato R, Beritelli F, Lombardo A, et al. Lung-DT: An AI-Powered Digital Twin Framework for Thoracic Health Monitoring and Diagnosis. Sensors (Basel), 2024, 24(3): 958. doi:10.3390/s24030958.
[14]	Farnia P, Velayati AA, Ghanavi J, et al. Tuberculosis: An Ongoing Global Threat. Adv Exp Med Biol, 2026, 1484: 1-31. doi:10.1007/978-3-031-96883-9_1.
[15]	张蕾洁, 李培, 王丹, 等. 基于三种分类模型的肺结核患者诊断延迟影响因素分析. 结核与肺部疾病杂志, 2025, 6(3): 335-342. doi:10.19983/j.issn.2096-8493.20250036.
[16]	Rehan MW, Rehan MM. Survey, taxonomy, and emerging paradigms of societal digital twins for public health preparedness. NPJ Digit Med, 2025, 8(1): 520. doi:10.1038/s41746-025-01737-5. URL pmid: 40804297
[17]	Pang JJ, Huang Y, Xie ZZ, et al. Collaborative City Digital Twin for the COVID-19 Pandemic:A Federated Learning Solution. Tsinghua Sci Tech, 2021, 26(5): 759-771. doi:10.26599/TST.2021.9010026.
[18]	Venkatachalam I, Conceicao EP, Sim JXY, et al. Three-Dimensional Disease Outbreak Surveillance System in a Tertiary Hospital in Singapore: A Proof of Concept. Mayo Clin Proc Digit Health, 2023, 1(2): 172-184. doi:10.1016/j.mcpdig.2023.04.001. URL pmid: 40206728
[19]	Zhan Y, Wang Y, Zhang W, et al. Diagnostic Accuracy of the Artificial Intelligence Methods in Medical Imaging for Pulmonary Tuberculosis: A Systematic Review and Meta-Analysis. J Clin Med, 2022, 12(1): 303. doi:10.3390/jcm12010303.
[20]	Wu J, Koelzer VH. Towards generative digital twins in biomedical research. Comput Struct Biotechnol J, 2024, 23: 3481-3488. doi:10.1016/j.csbj.2024.09.030.
[21]	朱庆东, 赵春艳, 谢周华, 等. 基于人工智能的CT影像组学在结核病诊断和治疗反应监测中应用的研究进展. 中国防痨杂志, 2025, 47(8): 1068-1076. doi:10.19982/j.issn.1000-6621.20250149.
[22]	闭德武, 罗晓成, 何华伟, 等. 618例耐多药结核病患者流行病学特征研究. 结核与肺部疾病杂志, 2025, 6(S1): 47-51. doi:10.19983/j.issn.2096-8493.20253076.
[23]	李汶翰, 杨静, 李春华. 人工智能在肺结核影像诊断及耐药性预测中的研究进展. 中国防痨杂志, 2024, 46(9):1098-1103. doi:10.19982/j.issn.1000-6621.20240123.
[24]	Sethanan K, Pitakaso R, Srichok T, et al. Computer-aided diagnosis using embedded ensemble deep learning for multiclass drug-resistant tuberculosis classification. Front Med (Lausanne), 2023, 10: 1122222. doi:10.3389/fmed.2023.1122222.
[25]	Jiang F, Xu C, Wang Y, et al. A CT-based radiomics analyses for differentiating drug resistant and drug-sensitive pulmonary tuberculosis. BMC Med Imaging, 2024, 24(1): 307. doi:10.1186/s12880-024-01481-4.
[26]	Padoan A, Plebani M. Dynamic mirroring: unveiling the role of digital twins, artificial intelligence and synthetic data for personalized medicine in laboratory medicine. Clin Chem Lab Med, 2024, 62(11): 2156-2161. doi:10.1515/cclm-2024-0517. URL pmid: 38726708
[27]	Subbiah V. The next generation of evidence-based medicine. Nat Med, 2023, 29(1): 49-58. doi:10.1038/s41591-022-02160-z. URL pmid: 36646803
[28]	Ma JB, Zeng LC, Ren F, et al. Development and validation of a prediction model for unsuccessful treatment outcomes in patients with multi-drug resistance tuberculosis. BMC Infect Dis, 2023, 23(1): 289. doi:10.1186/s12879-023-08193-0. URL pmid: 37147607
[29]	Nijiati M, Guo L, Abulizi A, et al. Deep learning and radiomics of longitudinal CT scans for early prediction of tuberculosis treatment outcomes. Eur J Radiol, 2023, 169: 111180. doi:10.1016/j.ejrad.2023.111180.
[30]	Nardone V, Reginelli A, Rubini D, et al. Delta radiomics: an updated systematic review. Radiol Med, 2024, 129(8):1197-1214. doi:10.1007/s11547-024-01853-4. URL pmid: 39017760
[31]	Volkov I, Radchenko G, Tchernykh A. Digital Twins, Internet of Things and Mobile Medicine: A Review of Current Platforms to Support Smart Healthcare. Programming and Computer Software, 2021, 47(8):578-590. doi:10.1134/S0361768821080284.
[32]	Wang M, Hu H, Wu S. Opportunities and challenges of digital twin technology in healthcare. Chin Med J (Engl), 2023, 136(23):2895-2896. doi:10.1097/CM9.0000000000002896.
[33]	Cheng Q, Chen P, Dai R, et al. Comparative Effectiveness of Digital Health Technologies in Tuberculosis Treatment: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. JMIR Mhealth Uhealth, 2025, 13: e75424. doi:10.2196/75424.
[34]	Braun M. Represent me: please! Towards an ethics of digital twins in medicine. J Med Ethics, 2021: medethics-2020-106134. doi:10.1136/medethics-2020-106134.
[35]	Meijer C, Uh HW, El Bouhaddani S. Digital Twins in Healthcare: Methodological Challenges and Opportunities. J Pers Med, 2023, 13(10):1522. doi:10.3390/jpm13101522.
[36]	de Kerckhove D. The personal digital twin, ethical considerations. Philos Trans A Math Phys Eng Sci, 2021, 379(2207):20200367. doi:10.1098/rsta.2020.0367.
[37]	Chronaki C, Markatos E. xShare-Powered Personal Digital Twins: End of Privacy or Key to Precision Health?. Stud Health Technol Inform, 2025, 329:1119-1124. doi:10.3233/SHTI251013. URL pmid: 40776031
[38]	Sun C, van Soest J, Dumontier M. Generating synthetic personal health data using conditional generative adversarial networks combining with differential privacy. J Biomed Inform, 2023, 143:104404. doi:10.1016/j.jbi.2023.104404.
[39]	Huang PH, Kim KH, Schermer M. Ethical Issues of Digital Twins for Personalized Health Care Service: Preliminary Mapping Study. J Med Internet Res, 2022, 24(1): e33081. doi:10.2196/33081.
[40]	Bandeira N, Deutsch EW, Kohlbacher O, et al. Data Management of Sensitive Human Proteomics Data: Current Practices, Recommendations, and Perspectives for the Future. Mol Cell Proteomics, 2021, 20:100071. doi:10.1016/j.mcpro.2021.100071.
[41]	Zou PXW, Ma S. How digital twin technology may improve safety management: A multi-industry perspective. Safety Science, 2025: 189. doi:10.1016/j.ssci.2025.106837.
[42]	He X, Liu X, Zuo F, et al. Artificial intelligence-based multi-omics analysis fuels cancer precision medicine. Semin Cancer Biol, 2023, 88:187-200. doi:10.1016/j.semcancer.2022.12.009. URL pmid: 36596352
[43]	Sadée C, Testa S, Barba T, et al. Medical digital twins: enabling precision medicine and medical artificial intelligence. Lancet Digit Health, 2025, 7(7): 100864. doi:10.1016/j.landig.2025.02.004.
[44]	He QQ, Li L, Dai L, et al. From Digital Human Modeling to Human Digital Twin: Framework and Perspectives in Human Factors. Chinese Journal of Mechanical Engineering, 2024, 37(1):1-14. doi:10.1186/s10033-024-00998-7.
[45]	Demir O, Uslan I, Buyuk M, et al. Development and validation of a digital twin of the human lower jaw under impact loading by using non-linear finite element analyses. J Mech Behav Biomed Mater, 2023, 148:106207. doi:10.1016/j.jmbbm.2023.106207.
[46]	Wang T, Li J, Deng Y, et al. Digital twin for human-machine interaction with convolutional neural network. Int J Comput Integr Manuf, 2021, 34(7-8): 888-897. doi:10.1080/0951192X.2021.1925966.
[47]	Joslyn LR, Linderman JJ, Kirschner DE. A virtual host model of Mycobacterium tuberculosis infection identifies early immune events as predictive of infection outcomes. J Theor Biol, 2022, 539:111042. doi:10.1016/j.jtbi.2022.111042.
[48]	Juárez MA, Pennisi M, Russo G, et al. Generation of digital patients for the simulation of tuberculosis with UISS-TB. BMC Bioinformatics, 2020, 21(Suppl 17):449. doi:10.1186/s12859-020-03776-z. URL pmid: 33308156
[49]	Pitaloka DAE, Syamsunarno MRAAA, Abdulah R, et al. Omics Biomarkers for Monitoring Tuberculosis Treatment: A Mini-Review of Recent Insights and Future Approaches. Infect Drug Resist, 2022, 15:2703-2711. doi:10.2147/IDR.S366580. URL pmid: 35664683
[50]	Wu C, Zhou F, Ren J, et al. A Selective Review of Multi-Level Omics Data Integration Using Variable Selection. High Throughput, 2019, 8(1):4. doi:10.3390/ht8010004.
[51]	Montaner J, Ramiro L, Simats A, et al. Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke. Nat Rev Neurol, 2020, 16(5): 247-264. doi:10.1038/s41582-020-0350-6. URL pmid: 32322099
[52]	Klassert TE, Goyal S, Stock M, et al. AmpliSeq Screening of Genes Encoding the C-Type Lectin Receptors and Their Signaling Components Reveals a Common Variant in MASP1 Associated with Pulmonary Tuberculosis in an Indian Population. Front Immunol, 2018, 9: 242. doi:10.3389/fimmu.2018.00242. URL pmid: 29515573
[53]	Subramanian I, Verma S, Kumar S, et al. Multi-omics Data Integration, Interpretation, and Its Application. Bioinform Biol Insights, 2020, 14: 1177932219899051. doi:10.1177/1177932219899051.
[54]	Thu VTA, Dat LD, Jayanti RP, et al. Advancing personalized medicine for tuberculosis through the application of immune profiling. Front Cell Infect Microbiol, 2023, 13: 1108155. doi:10.3389/fcimb.2023.1108155.
[55]	Stenseth NC, Schlatte R, Liu X, et al. How to avoid a local epidemic becoming a global pandemic. Proc Natl Acad Sci U S A, 2023, 120(10): e2220080120. doi:10.1073/pnas.2220080120.